Circulating tumor cell quantification during abiraterone plus prednisone therapy may estimate survival in metastatic castration-resistant prostate cancer patients-Reference-Cited by-同舟云学术

Circulating tumor cell quantification during abiraterone plus prednisone therapy may estimate survival in metastatic castration-resistant prostate cancer patients

Published:2023-01-29 Issue:4 Volume:55 Page:883-892
ISSN:1573-2584
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Gu Tengfei,Li Jie,Chen Ting,Zhu Qingfeng,Ding Jiafeng^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s11255-023-03481-9.pdf

Reference35 articles.

1. Mansinho A, Macedo D, Fernandes I, Costa L (2018) Castration-resistant prostate cancer: mechanisms, targets and treatment. Adv Exp Med Biol 1096:117–133. https://doi.org/10.1007/978-3-319-99286-0_7

2. Aurilio G, Cimadamore A, Mazzucchelli R, Lopez-Beltran A, Verri E, Scarpelli M, Massari F, Cheng L, Santoni M, Montironi R (2020) Androgen receptor signaling pathway in prostate cancer: from genetics to clinical applications. Cells. https://doi.org/10.3390/cells9122653

3. Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, Ateeq B, Chun SY, Siddiqui J, Sam L, Anstett M, Mehra R, Prensner JR, Palanisamy N, Ryslik GA, Vandin F, Raphael BJ, Kunju LP, Rhodes DR, Pienta KJ, Chinnaiyan AM, Tomlins SA (2012) The mutational landscape of lethal castration-resistant prostate cancer. Nature 487(7406):239–243. https://doi.org/10.1038/nature11125

4. Foley C, Mitsiades N (2016) Moving beyond the androgen receptor (AR): targeting AR-interacting proteins to treat prostate cancer. Horm Cancer 7(2):84–103. https://doi.org/10.1007/s12672-015-0239-9

5. Zhou J, Wang Y, Wu D, Wang S, Chen Z, Xiang S, Chan FL (2021) Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer. Oncogene 40(15):2625–2634. https://doi.org/10.1038/s41388-021-01737-1

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic Review;European Urology Oncology;2024-05